Keywords
How to Cite
Abstract
Cardiovascular pathology is one of the frequent comorbidities in patients with chronic obstructive pulmonary disease, due to both genetic predisposition and common risk factors (smoking, senile age, male gender, sedentary lifestyle, obesity). The article shows that development of endothelial dysfunction is one of the earliest phases of pathogenesis in this setting. Endothelial dysfunction mechanisms are defined and characterized, including an imbalance of vasoconstricting and vasodilating agents with the emergence of "vicious circles" that violate hemo-vascular homeostasis. The role of nitric oxide, endothelin-1, intercellular adhesion molecule-1 (ICAM-1) in the development of endothelial dysfunction in COPD patients is discussed.
The article defines the concept of oxidative stress, the most potent oxidants and mechanisms of their damaging effect arebeing listed. A particular attention is paid to 8-isoprostane as a golden standard in assessment of oxidative stress in patients with COPD .
References
References
Lopez, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A. L., Held, L. S., ... & Buist, S. (2006). Chronic obstructive pulmonary disease: current burden and future projections. European Respiratory Journal, 27(2), 397-412. doi.org/10.1183/09031936.06.00025805
Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine, 3(11), e442. doi.org/10.1371/journal.pmed.0030442
Trupin, L., Earnest, G., San Pedro, M., Balmes, J. R., Eisner, M. D., Yelin, E., ... & Blanc, P. D. (2003). The occupational burden of chronic obstructive pulmonary disease. European Respiratory Journal, 22(3), 462-469. doi.org/10.1183/09031936.03.00094203
Dahl, R., Chung, K. F., Buhl, R., Magnussen, H., Nonikov, V., Jack, D., ... & Kramer, B. (2010). Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax, 65(6), 473-479. doi.org/10.1136/thx.2009.125435
Feshhenko, Ju. I. (2009). HOZL v Ukraine: problemy i puti reshenija. Zdorov’ja Ukraїni, 9(1), 3−4 (in Russian).
Global'naja strategija diagnostiki, lechenija i profilaktiki HOBL. Peresmotr 2011 g. Per. s angl. / pod red. A.S. Belevskogo. M.: Rossijskoe respiratornoe obshhestvo, 2012. 80s. [Global Initiative for Chronic Obstructive Lung Diseases. Global Strategy for Diagnosis, Management and Prevention for Chronic Obstructive Lung Diseases (Revised 2011). Rossiyskoe Respiratornoye Obschestvo Publ., 2012 (in Russian)].
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008). Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. European Respiratory Journal, 32(4), 962-969. doi.org/10.1183/09031936.00012408
Ovcharenko, S. I. (2018). Serdechno-sosudistaja patologija u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih: kak my lechim?. RMZh, 26(10-1), 36-39 [Ovcharenko, S.I. (2018). Cardiovascular pathology in patients with chronic obstructive pulmonary disease: how do we treat it? RMJ. 10 (I), 36–39] (in Russian).
Babak, O. Ja., Shaposhnikova, Ju. N., & Nemcova, V. D. (2004). Arterial'naja gipertenzija i ishemicheskaja bolezn' serdca-jendotelial'naja disfunkcija: sovremennoe sostojanie voprosa. Ukrainskij terapevticheskij zhurnal, (1), 14-22.
Chuchalin, A. G. (2008). Hronicheskaja obstruktivnaja bolezn' legkih i soputstvujushhie zabolevanija. Pul'monologija, (2), 5-14 (in Russian).
Feary. J, & Branes N. (2009). Abstract, ERS, 19 Annual Congress. sept.13. P. 962.
Brodskaja, T. A., Nevzorova, V. A., Gelcer, B. I., & Motkina, E. V. (2007). Jendotelial'naja disfunkcija i bolezni organov dyhanija. Terapevticheskij arhiv, 79(3), 76-84 (in Russian).
Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., & Kalayci, O. (2012). Oxidative stress and antioxidant defense. World Allergy Organization Journal, 5(1), 9-19.doi.org/10.1097/wox.0b013e3182439613
Kovaljova, O. N., Ashcheulova, T. V., Gerasimchuk, N. N., & Safargalina-Kornilo-va, N. A. (2015). Rol'oksidativnogo stressa v stanovlenii i progressirovanii gipertonicheskoj bolezni [Role of oxidative stress in the formation and progression of hypertensive disease]. Nauchnye Vedomosti Belgorodskogo Gosudarstvennogo Universiteta Medicina Farmacija, Aktual'nye problemy mediciny, 29(4(201)), 5-10 (in Russian).
Rahman, I., & Adcock, I. M. (2006). Oxidative stress and redox regulation of lung inflammation in COPD. European respiratory journal, 28(1), 219-242. doi.org/10.1183/09031936.06.00053805
Yin, H. (2008). New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo. Biofactors, 34(2), 109-124. doi.org/10.1002/biof.5520340203
Herasymchuk, N. (2018). 8-isoprostane as the main marker of oxidative stress. Zaporozhye medical journal. Volume 20. No. 6 (11), 2018, - 853-859. doi.org/10.14739/2310-1210.2018.6.146780
Horváth, I., Hunt, J., & Barnes, P. J. (2005). Exhaled breath condensate: methodological recommendations and unresolved questions.
European Respiratory Journal,26(3), 523-548. doi.org/10.1183/09031936.05.00029705
Kostikas, K., Papatheodorou, G., Psathakis, K., Panagou, P., & Loukides, S. (2003). Oxidative stress in expired breath condensate of patients with COPD. Chest, 124(4), 1373-1380. doi.org/10.1378/chest.124.4.1373
Montuschi, P., Collins, J. V., Ciabattoni, G., Lazzeri, N., Corradi, M., Kharitonov, S. A., & Barnes, P. J. (2000). Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. American journal of respiratory and critical care medicine, 162(3), 1175-1177.doi.org/10.1164/ajrccm.162.3.2001063
Antczak, A., Ciebiada, M., Pietras, T., Piotrowski, W. J., Kurmanowska, Z., & Górski, P. (2012). Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease. Archives of medical science: AMS, 8(2), 277-285. oi.org/10.5114/aoms.2012.28555
Biernacki, W. A., Kharitonov, S. A., & Barnes, P. J. (2003). Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax, 58(4), 294-298. doi.org/10.1136/thorax.58.4.294
Anaev, Je. H., Kushaeva, M. Je., & Kurova, V. S. (2012). Znachenie proteomnogo analiza kondensata vydyhaemogo vozduha pri diagnostike HOBL i pnevmonii. Pul'monologija. 5, 5–9.
Ko, F. W., Lau, C. Y., Leung, T. F., Wong, G. W., Lam, C. W., & Hui, D. S. (2006). Exhaled breath condensate levels of 8-isoprostane, growth related oncogene α and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respiratory medicine, 100(4), 630-638. doi.org/10.1016/j.rmed.2005.08.009
Wanner, A., & Mendes, E. S. (2010). Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research. American journal of respiratory and critical care medicine, 182(11), 1344-1351. doi.org/10.1164/rccm.201001-0038pp
Malaja, L. T., Korzh, A. N., & Balkovaja, L. B. (2000). Jendotelial'naja disfunkcija pri patologii serdechno-sosudistoj sistemy. Har'kov: Torsing, 432 (in Russian).
Hall C. (2001). The value of natriuretic peptides for the management of heart failure: current state of play. European Journal of Heart Failure. 3(4): 395–397. doi.org/10.1016/s1388-9842(01)00151-9
Ashheulova, T. V., Kovaleva, O. N., Gerasimchuk, N. N., & Safargalina-Kornilova, N. A. (2016). Funkcional'noe sostojanie jendotelija i aktivnost' provospalitel'nyh citokinov u bol'nyh gipertonicheskoj bolezn'ju, associirovannoj s ozhireniem [Endothelial function and activity of proinflammatory cytokines in patients with hypertension associated with obesity]. Nauchnye Vedomosti Belgorodskogo Gosudarstvennogo Universiteta Medicina Farmacija, Aktual'nye problemy mediciny, 34(12 (233)), 5-14 (in Russian).
Ribeiro, F., Alves, A. J., Teixeira, M., Ribeiro, V., Duarte, J. A., & Oliveira, J. (2009). Endothelial function and atherosclerosis: circulatory markers with clinical usefulness. Revista portuguesa de cardiologia: orgao oficial da Sociedade Portuguesa de Cardiologia= Portuguese journal of cardiology: an official journal of the Portuguese Society of Cardiology, 28(10), 1121-1151.
Lapshina, L. A., Molodan, V. I., Shevchenko, O. S., & Nemcova, V. D. (2001). Jendotelial'naja disfunkcija pri nachal'nyh stadijah arterial'noj gipertenzii i sposoby ee nemedikamentoznoj korrekcii. Ukrainskij terapevticheskij zhurnal, 3(4), 39 (in Russian).
Danilenko, S. A., & Landyshev, Ju. S. (2010). Mikrogemocirkuljatornye narushenija v slizistoj obolochke bronhov pri hronicheskoj obstruktivnoj bolezni legkih. Regionarnoe krovoobrashhenie i mikrocirkuljacija, 9(1), 38-41 (in Russian).
Van Suylen, R. J., Smits, J. F., & Daemen, M. J. (1998). Pulmonary artery remodeling differs in hypoxia-and monocrotaline-induced pulmonary hypertension. American journal of respiratory and critical care medicine, 157(5), 1423-1428 (in Russian). doi.org/10.1164/ajrccm.157.5.9709050
Bakakos, P., Patentalakis, G., & Papi, A. (2016). Vascular Biomarkers in Asthma and COPD. Curr Top Med Chem. 16(14), 1599-1609. doi.org/10.2174/1568026616666150930121157
Shao, D., Park, J. E., & Wort, S. J. (2011). The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension. Pharmacological Research, 63(6), 504-511. doi.org/10.1016/j.phrs.2011.03.003
Almagro, P., Cabrera, F. J., Diez, J., Boixeda, R., Ortiz, M. B. A., Murio, C., & Soriano, J. B. (2012). Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPDComorbidity and Prognosis in COPD Hospitalized Patients The EPOC en Servicios de Medicina Interna (ESMI) Study. Chest Journal, 142(5), 1126-1133. doi.org/10.1378/chest.11-2413
Mannino, D. M., & Sanderson, W. T. (2017). Using big data to reveal chronic respiratory disease mortality patterns and identify potential public health interventions. Jama, 318(12), 1112-1114. doi.org/10.1001/jama.2017.11746
Ives, S. J., Harris, R. A., Witman, M. A., Fjeldstad, A. S., Garten, R. S., McDaniel, J., ... & Richardson, R. S. (2014). Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension, 63(3), 459-467. doi.org/10.1161/hypertensionaha.113.02255
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003). Chronic obstructive pulmonary disease: molecular and cellularmechanisms. European Respiratory Journal, 22(4), 672-688. doi.org/10.1183/09031936.03.00040703
Makarova, M. A., Avdeev, S. N., & Chuchalin, A. G. (2014). Arterial'naja rigidnost' i jendotelial'naja disfunkcija u pacientov s hronicheskoj obstruktivnoj bolezn'ju legkih: chto pervichno? [Arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease: what is primary and secondary?] Pul'monologija, (6), 73-79 (in Russian). doi.org/10.18093/0869-0189-2011-0-6-73-79
Оеlsnеr, Е.C., Pоttingеr, T.D., Burkаrt, K.M., & Аllisоn, M. (2013). Аdhеsiоnmоlеculеs, еndоthеlin-1 аnd lung functiоni n sеvеn pоpulаtiоn-bаsеdcоhоrts. Biоmаrkеrs; 18 (3), 196–203.
Wаltеr, R.E., Wilk, J.B., Lаrsоn, M.G., & Vаsаn RS. (2008). Systеmic inflаmmаtiоn аnd CОPD: thе Frаminghаm Hеаrt Study. Chеst; 133 (1), 19–25.
Hе, Z. J. H., & Zhi, H. X. Z. (2010). Intеgrin-аssоciаtеd prоtеins in blооd plаsmа оf pаtiеnts with аcutееxаcеrbаtiоn оf chrоnic оbstructivе pulmоnаry disеаsе. Аrticlе in Chinеsе, 33(4), 265-7.
Riise, G. C., Larsson, S., Lofdahl, C. G., & Andersson, B. A. (1994). Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. European Respiratory Journal, 7(9), 1673-1677. doi.org/10.1183/09031936.94.07091673
Pollock, D. M. (2005). Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension, 45(4), 477-480.
Ashheulova, T. V., Zaika, M. V., & Gerasimchuk, N. N. (2007). Vzaimosvjaz' immunnoj aktivacii i oksidativnogo stressa pri progressirovanii arterial'noj gipertenzii. [The relationship between immune activation and oxidative stress in the progression of arterial hypertension]. Ukrainskij terapevticheskij zhurnal, 2, 12-15 (in Russian).
Barua, R. S., Ambrose, J. A., Eales-Reynolds, L. J., DeVoe, M. C., Zervas, J. G., & Saha, D. C. (2001). Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation, 104(16), 1905-1910. doi.org/10.1161/hc4101.097525
Butler, R., Morris, A. D., & Struthers, A. D. (2001). Cigarette smoking in men and vascular responsiveness. British journal of clinical pharmacology, 52(2), 145-149. doi.org/10.1046/j.0306-5251.2001.01434.x
Karoli, N. A., & Rebrov, A. P. (2004). Vlijanie kurenija na razvitie jendotelial'noj disfunkcii u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih. Pul'monologija, 2(14), 70-78.
Laurent, S., Katsahian, S., Fassot, C., Tropeano, A. I., Gautier, I., Laloux, B., & Boutouyrie, P. (2003). Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke, 34(5), 1203-1206. doi.org/10.1161/01.str.0000065428.03209.64
Mahendra, M., Kumar, S., Desai, N., Jayaraj, B. S., & Mahesh, P. A. (2018). Evaluation for airway obstruction in adult patients with stable ischemic heart disease. Indian heart journal, 70(2), 266-271. doi.org/10.1016/j.ihj.2017.08.003.
Ratova, L. G., Zykov, K. A., Dolgusheva, Ju. A., Agapova, O. Ju., Nazarov, B. M., & Chazova, I. E. (2012). Arterial'naja gipertonija i bronhoobstruktivnaja patologija-osobennosti klinicheskoj kartiny. Sistemnye gipertenzii, 9(1), 54–59. [Arterial'naya gipertoniya i bronkhoobstruktivnaya patologiya - osobennosti klinicheskoy kartiny] (in Russian). doi.org/10.26442/SG33169
Ovcharenko, S., I., Nersesyan, Z., N., & Morozova, T., E.. (2014). Chronic obstructive pulmonary disease combined with arterial hypertension: efficacy and safety ofthesustained-release indapamide (Arifon® retard) Systemic Hypertension, 11(2).54-58. doi.org/10.26442/sg29026
Triest, F. J., Studnicka, M., Franssen, F. M., Vollmer, W. M., Lamprecht, B., Wouters, E. F., ... & Vanfleteren, L. E. (2019). Airflow obstruction and cardio-metabolic comorbidities. COPD: Journal of Chronic Obstructive Pulmonary Disease, 16(2), 109-117. doi.org/10.1080/15412555.2019.1614550
Malo de Molina, R., Aguado, S., Arellano, C., Valle, M., & Ussetti, P. (2018). Ischemic heart disease during acute exacerbations of COPD. Medical Sciences, 6(4), 83. doi.org/10.3390/medsci6040083
Khassawneh, B. Y., Samrah, S. M., Jarrah, M. I., Ibdah, R. K., Ibnian, A. M., Almistarehi, A. W., ... & Khader, Y. S. (2018). Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan. International journal of chronic obstructive pulmonary disease, 13, 2759-2766. doi:10.2147/COPD.S172679 PMCID: PMC6130534.
Biscaglia, S., Ruggiero, R., Di Cesare, A., Serenelli, M., & Ferrari, R. (2019). Angina and chronic obstructive pulmonary disease: facing the perfect storm. European Heart Journal Supplements, 21(Supplement_C), 17-20. doi.org/10.1093/eurheartj/suz042
Almagro, P., De la Sierra, A., Acosta, E., Navarro, A., Garcia, M. E., Valdivieso, S., ... & Agustí, A. (2018). Spirometrically confirmed chronic obstructive pulmonary disease worsens long-term prognosis after percutaneous coronary intervention. American journal of respiratory and critical care medicine, 197(6), 824-826. doi.org/10.1164/rccm.201707-1389le
Andersson, C., Hansen, P. W., Steffensen, I. E., Andreasen, C., Weeke, P. E., Køber, L., ... & Torp-Pedersen, C. (2019). Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure–A danish nationwide registry-based study. European journal of internal medicine, 63, 56-61. doi.org/10.1016/j.ejim.2019.02.014
Bazargan, M., Smith, J. L., Robinson, P., Uyanne, J., Abdulrahoof, R., Chuku, C., & Assari, S. (2019). Chronic respiratory disease and health-related quality of life of African American older adults in an economically disadvantaged area of Los Angeles. International journal of environmental research and public health, 16(10), 1756. doi.org/10.3390/ijerph16101756
Ellingsen, J., Johansson, G., Larsson, K., Lisspers, K., Malinovschi, A., Ställberg, B., ... & Janson, C. (2020). Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD–Real-World Data from a Primary Care Setting. International journal of chronic obstructive pulmonary disease, 15, 235. doi: 10.2147/COPD.S231296.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.